Literature DB >> 25253483

Bifidobacterium--friend or foe? A case of urinary tract infection with Bifidobacterium species.

Poonam Pathak1, Cheryl Trilligan2, Alwyn Rapose1.   

Abstract

Bifidobacterium-a commensal of the human intestine is considered non-pathogenic and has been advocated as a probiotic due to its potential beneficial effects. However, there have been case reports implicating bifidobacteria as pathogenic agents in a variety of different infectious conditions. We discuss here one such case of a complicated urinary tract infection associated with Bifidobacterium spp. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25253483      PMCID： PMC4173150          DOI： 10.1136/bcr-2014-205122

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  16 in total

Review 1.  Safety of probiotics that contain lactobacilli or bifidobacteria.

Authors:  S P Borriello; W P Hammes; W Holzapfel; P Marteau; J Schrezenmeir; M Vaara; V Valtonen
Journal:  Clin Infect Dis       Date:  2003-03-05       Impact factor: 9.079

2.  Bifidobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy.

Authors:  Andreas Jenke; Eva-Maria Ruf; Thomas Hoppe; Michael Heldmann; Stefan Wirth
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2011-11-04       Impact factor: 5.747

3.  Bifidobacterium inopinatum sp. nov. and Bifidobacterium denticolens sp. nov., two new species isolated from human dental caries.

Authors:  F Crociani; B Biavati; A Alessandrini; C Chiarini; V Scardovi
Journal:  Int J Syst Bacteriol       Date:  1996-04

4.  Recurrent urinary infection with Bifidobacterium scardovii.

Authors:  Claudia M Barberis; Roxana M Cittadini; Marisa N Almuzara; Alejandro Feinsilberg; Angela M Famiglietti; Maria Soledad Ramírez; Carlos A Vay
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

5.  Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.

Authors:  P Hütt; J Shchepetova; K Lõivukene; T Kullisaar; M Mikelsaar
Journal:  J Appl Microbiol       Date:  2006-06       Impact factor: 3.772

6.  Case of sepsis caused by Bifidobacterium longum.

Authors:  G Y Ha; C H Yang; H Kim; Y Chong
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

Review 7.  The therapeutic effect of probiotic bacteria on gastrointestinal diseases.

Authors:  Jolanta Sarowska; Irena Choroszy-Król; Bożena Regulska-Ilow; Magdalena Frej-Mądrzak; Agnieszka Jama-Kmiecik
Journal:  Adv Clin Exp Med       Date:  2013 Sep-Oct       Impact factor: 1.727

8.  Antipathogenic activity of probiotics against Salmonella Typhimurium and Clostridium difficile in anaerobic batch culture systems: is it due to synergies in probiotic mixtures or the specificity of single strains?

Authors:  Sandra Tejero-Sariñena; Janine Barlow; Adele Costabile; Glenn R Gibson; Ian Rowland
Journal:  Anaerobe       Date:  2013-09-30       Impact factor: 3.331

9.  Site and clinical significance of Alloscardovia omnicolens and Bifidobacterium species isolated in the clinical laboratory.

Authors:  Steven D Mahlen; Jill E Clarridge
Journal:  J Clin Microbiol       Date:  2009-07-29       Impact factor: 5.948

10.  Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model.

Authors:  Laetitia Rodes; Afshan Khan; Arghya Paul; Michael Coussa-Charley; Daniel Marinescu; Catherine Tomaro-Duchesneau; Wei Shao; Imen Kahouli; Satya Prakash
Journal:  J Microbiol Biotechnol       Date:  2013-04       Impact factor: 2.351
View more
  6 in total

1.  Altered gut microbiota in Rett syndrome.

Authors:  Francesco Strati; Duccio Cavalieri; Davide Albanese; Claudio De Felice; Claudio Donati; Joussef Hayek; Olivier Jousson; Silvia Leoncini; Massimo Pindo; Daniela Renzi; Lisa Rizzetto; Irene Stefanini; Antonio Calabrò; Carlotta De Filippo
Journal:  Microbiome       Date:  2016-07-30       Impact factor: 14.650

Review 2.  Cancer-Associated Microbiota: From Mechanisms of Disease Causation to Microbiota-Centric Anti-Cancer Approaches.

Authors:  Priyankar Dey; Saumya Ray Chaudhuri
Journal:  Biology (Basel)       Date:  2022-05-16

3.  Bifidobacterium: An Emerging Clinically Significant Metronidazole-resistant Anaerobe of Mixed Pyogenic Infections.

Authors:  Hena Butta; Raman Sardana; Raju Vaishya; Kailash N Singh; Leena Mendiratta
Journal:  Cureus       Date:  2017-04-04

4.  Endometrial microbiota composition is associated with reproductive outcome in infertile patients.

Authors:  Inmaculada Moreno; Iolanda Garcia-Grau; David Perez-Villaroya; Marta Gonzalez-Monfort; Mustafa Bahçeci; Marcelo J Barrionuevo; Sagiri Taguchi; Elena Puente; Michael Dimattina; Mei Wei Lim; Georgina Meneghini; Mira Aubuchon; Mark Leondires; Alexandra Izquierdo; Martina Perez-Olgiati; Alejandro Chavez; Ken Seethram; Davide Bau; Carlos Gomez; Diana Valbuena; Felipe Vilella; Carlos Simon
Journal:  Microbiome       Date:  2022-01-04       Impact factor: 14.650

5.  Peribronchial Connective Tissue Infection Caused by Bifidobacterium longum and Veillonella Species Mimicking Lung Cancer.

Authors:  Yasuo Takiguchi; Masaru Nagayosi; Yukiko Matsuura; Yoko Akiba; Akira Naito
Journal:  Intern Med       Date:  2020-09-19       Impact factor: 1.271

6.  Gut Microbiome and Plasma Metabolome Signatures in Middle-Aged Mice With Cognitive Dysfunction Induced by Chronic Neuropathic Pain.

Authors:  Dongyu Hua; Shan Li; Shiyong Li; Xuan Wang; Yue Wang; Zheng Xie; Yilin Zhao; Jie Zhang; Ailin Luo
Journal:  Front Mol Neurosci       Date:  2022-01-04       Impact factor: 5.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.